Stem Cell Cosmetics
Links shared publicly online about this topic
medicalnewstoday.com — “Controlling the amount of oxygen that stem cells are exposed to can significantly increase the effectiveness of a procedure meant to combat an often fatal form of muscular dystrophy, according to” View full resource at medicalnewstoday.com
Most Recently Shared on August 24, 2012 at 7:05 am By:
Most Recently Shared on July 19, 2011 at 1:04 am By:
Most Recently Shared on September 7, 2009 at 10:28 pm By:
newswise.com — “Stem cells provide a recurring topic among the scientific presentations at the Genetics Society of America’s 53rd Annual Drosophila Research Conference, March 7-11 in Chicago. Specifically, researchers are trying to determine how, within organs, cells specialize while stem cells maintain tissues and enable them to repair damage and respond to stress or aging.” View full resource at newswise.com
Most Recently Shared on March 10, 2012 at 3:49 am By:
Most Recently Shared on April 25, 2012 at 4:01 pm By:
sciencedaily.com — “To date, few fundamentals have been known about the most common gland in the body, the sweat glands that are essential to controlling body temperature, allowing humans to live in the world’s diverse climates. Now, in a tour de force, researchers have identified, in mice, the stem cell from which sweat glands initially develop as well as stem cells that regenerate adult sweat glands.” View full resource at sciencedaily.com
Most Recently Shared on July 21, 2012 at 12:25 am By:
medicalnewstoday.com — “Researchers have taken a step toward personalized medicine for Parkinson's disease, by investigating signs of the disease in patient-derived cells and testing how the cells respond to drug treatme” View full resource at medicalnewstoday.com
Most Recently Shared on July 6, 2012 at 7:05 am By:
The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells : Nature Genetics : Nature Publishing Group
nature.com — “Shaoguang Li and colleagues show that the Blk pathway functions as a tumor suppressor in cancer stem cells of chronic myeloid leukemia but has no effect on normal hematopoietic stem cells. These results support the feasibility of selectively targeting leukemic stem cells without harming the normal stem cell compartment.” View full resource at nature.com
Most Recently Shared on July 19, 2012 at 4:21 pm By:
thechart.blogs.cnn.com — “About 37 million Americans have some level of hearing problem, and science hasn't come up with a perfect solution to restore this valuable sense. Help may be on the way, at least in theory.” View full resource at thechart.blogs.cnn.com
Most Recently Shared on September 14, 2012 at 1:47 pm By:
Stem cell research offers new hope for unlocking the secrets of bipolar disorder | University of Michigan Health System
Most Recently Shared on August 22, 2011 at 10:34 am By:
medcitynews.com — “Athersys (NASDAQ:ATHX), which is developing stem cell treatments, will work with University Hospitals Cleveland on a phase 2 clinical trial for ischemic stroke.” View full resource at medcitynews.com
Most Recently Shared on February 23, 2012 at 3:40 pm By:
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma : Nature Medicine : Nature Publishing Group
nature.com — “The characterization of miR-380-5p-driven p53 repression provides a new mechanism for downmodulation of stress-induced antiproliferative responses in wild-type p53 contexts, including embryonic stem cells and neuroblastoma tumors. miR-380-5p potentiates Ras-induced mammary gland tumorigenesis and is frequently elevated in human neuroblastomas. miR-380-5p inactivation induces tumor cell death and shows therapeutic efficacy in orthotopic neuroblastoma models.” View full resource at nature.com
Most Recently Shared on October 2, 2010 at 2:46 pm By:
Most Recently Shared on November 1, 2011 at 4:35 am By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
The latest muscular dystrophy and ALS news published daily. Articles from research centers, universities and prestigious journals.
Organizing heart and blood resources shared by health experts, advocates, and organizations into WisdomCards.
Dr. Kim has over 15 years of healthcare experience as a provider, researcher, administrator, and educator. As Director of Health Outcomes at Eisai, Inc., in Woodcliff Lake, NJ, he was responsible for supporting value demonstration for neuroscience and oncology products. Previously he worked with Bristol-Myers Squibb where he led the health economics and outcomes research teams for psychiatric illness, HIV, and hepatitis B. A board-certified psychiatrist, Dr. Kim was vice chair of clinical programs at the Robert Wood Johnson Medical School, where he is a Clinical Associate Professor of Psychiatry. He received his bachelor’s degree from Harvard University and his MD from Jefferson Medical College, completing his psychiatric residency at Thomas Jefferson University Hospital. He earned an MBA from the University of Massachusetts at Amherst. As Medical Director of Adult Services at the University of Medicine and Dentistry of New Jersey – University Behavioral HealthCare, a statewide integrated behavioral delivery system, he was responsible for quality improvement, pharmacy, nursing, and laboratory services. Dr. Kim is a peer reviewer for several scientific journals, a grant reviewer for Congressionally Directed Medical Research Programs, and a member of the Medicare Evidence Development Coverage Advisory Committee. He has authored over 40 articles and book chapters.